1. Executive Summary
O’Vista is the first AI-powered eye-tracking platform that revolutionizes cognitive health and learning diagnostics by integrating Ripple’s blockchain technology for secure, decentralized data storage. Our system offers a non-invasive, real-time alternative to traditional cognitive and neurological assessments, enabling early detection of Alzheimer’s, personalized dyslexia support, and stroke rehabilitation.
By combining advanced AI, eye-tracking, and blockchain security, O’Vista ensures that users maintain full control of their data, researchers gain valuable decentralized insights, and institutions can leverage AI-driven diagnostics with transparency and efficiency.
2. Market Opportunity
Global Industry Breakdown
Cognitive Health Market (Alzheimer’s & Dementia Diagnosis) – $25+ Billion (Projected Growth by 2028)
EdTech for Learning Disabilities (Dyslexia & ADHD) – $10+ Billion
Stroke Rehabilitation Technology – $8+ Billion
AI-Powered Diagnostics & Health Data Blockchain Market – $40+ Billion
Competitive Advantage
First-mover in AI-driven eye-tracking for cognitive diagnostics
Faster, more affordable alternative to MRI & traditional neuro-testing
Blockchain integration ensures privacy, transparency, and user data ownership
OVI token facilitates transactions, research incentives, and decentralized storage access
3. How O’Vista Works
AI Eye-Tracking in Action
Users take a short, non-invasive eye-tracking test on their device.
AI algorithms analyze gaze behavior, fixation patterns, and saccades.
Neuro-markers indicate early cognitive changes linked to Alzheimer’s, dyslexia, or stroke recovery.
Ripple’s blockchain secures data, ensuring transparency and decentralized access.
OVI tokens enable seamless transactions and incentivized research participation.
4. Business & Revenue Model
Subscription-Based Cognitive Assessments for individuals, clinics & learning institutions
OVI Token Economy – Facilitates access to premium AI-driven analysis & research incentives
Enterprise Partnerships – AI-powered diagnostics for neuro-clinics, EdTech & health platforms
Data Licensing for AI Training – Securely anonymized eye-tracking datasets for research institutions
Government & Non-Profit Contracts – Large-scale cognitive health monitoring & literacy initiatives
5. How Ripple’s Blockchain Empowers O’Vista
Decentralized Data Ownership – Users control their neuro-health records securely on Ripple’s blockchain
Fast, Secure Transactions – OVI token enables instant, low-cost payments for diagnostics & AI assessments
Cross-Border Scalability – Ripple’s infrastructure allows seamless expansion into global healthcare & EdTech markets
AI-Verified Medical Records – Cognitive test results are permanently stored on the blockchain, preventing fraud & data tampering
6. Financial Projection & Funding Needs
Projected Revenue (First 3 Years)
Year 1: $5M (Early AI Assessment Subscriptions & OVI Token Adoption)
Year 2: $20M (Enterprise & Clinic Partnerships, Government Adoption)
Year 3: $50M+ (Global Expansion, AI Data Licensing, Research Market Penetration)
Funding Ask: $3M – $5M (Seed/Series A)
Use of Funds: AI Algorithm Development & System Expansion
Blockchain & OVI Token Integration for Global Scaling
Clinical Trials & Research Partnerships
Market Penetration in Key Regions (USA, EU, Asia)
Strategic Hiring (Neuroscientists, AI Engineers, Blockchain Developers)
7. Why Invest in O’Vista?
A first-of-its-kind AI eye-tracking & blockchain fusion in cognitive health & education
Large-scale industry disruption – replacing slow, costly cognitive assessments with AI-driven real-time diagnostics
Massive market demand in healthcare, education, and neuroscience research
Strategic partnership with Ripple blockchain ensures scalability, security & decentralization
Tokenized economy (OVI) unlocks revenue potential via assessments, research participation & decentralized data access
8. Next Steps & Call to Action
Join the O’Vista revolution & shape the future of AI-driven cognitive diagnostics!
Contact Us for Investment Opportunities